Diffuse large B-cell lymphoma with monoclonal immunoglobulin secretion

Diffuse large B-cell lymphoma with monoclonal immunoglobulin secretion

Blog Article

Aim.To provide the clinical characteristics of patients with diffuse large B-cell lymphoma (DLBCL) with monoclonal immunoglobulin secretion and Dual Inlet 5 Way Water Valve to evaluate the efficiency of intensified mNHL-BFM-90 or R-DA-EPOCH/R-HMA therapy programs in patients with Ig-secreting DLBCL.Subjects and methods.

A clinical trial was conducted in 93 patients with newly diagnosed DLBCL, among whom 21 (22.6%) were BIOTINE 5000MCG found to have monoclonal immunoglobulin secretion.Results.

Ig-secreting DLBCL is shown to be characterized by bone marrow involvement (p.